-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Haemonetics, Raises Price Target to $149

Benzinga·11/06/2026 21:48:04
Listen to the news
Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $123 to $149.